Assessment of Mechanisms of Improved Wound Healing
Public ClinicalTrials.gov record NCT00673309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Assessment of Mechanisms of Improved Wound Healing of Anabolic Agents and Diet in Severely Burned Patients
Study identification
- NCT ID
- NCT00673309
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Other
- Enrollment
- 644 participants
Conditions and interventions
Conditions
Interventions
- Stable Isotope Infusion study Procedure
- Insulin High Dose Drug
- oxandrolone Drug
- Propranolol Drug
- Growth Hormone Drug
- Insulin Low Dose Drug
- IGF-1/IGFBP-3 Drug
- Itraconazole Drug
- Growth Hormone and Propranolol Drug
- Oxandrolone and Propranolol Drug
- Placebo or Control Drug
Procedure · Drug
Eligibility (public fields only)
- Age range
- Up to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2000
- Primary completion
- Mar 31, 2011
- Completion
- Mar 31, 2013
- Last update posted
- Jul 2, 2023
2000 – 2013
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Texas Medical Branch | Galveston | Texas | 77550 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00673309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2023 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00673309 live on ClinicalTrials.gov.